Jynneos vaccine

Kathryn Dzintars, Pharm.D., BCPS
Jynneos vaccine is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

VACCINE TYPE

  • Attenuated live non-replicating smallpox and monkeypox vaccine (modified vaccinia Ankara; MVA) eliciting both humoral and cellular responses to orthopoxviruses.
    • Available for adults 18 years of age and older who are determined to be at high risk for smallpox or monkeypox infection.
    • This vaccine is part of the Strategic National Stockpile (SNS).

-- To view the remaining sections of this topic, please or --

VACCINE TYPE

  • Attenuated live non-replicating smallpox and monkeypox vaccine (modified vaccinia Ankara; MVA) eliciting both humoral and cellular responses to orthopoxviruses.
    • Available for adults 18 years of age and older who are determined to be at high risk for smallpox or monkeypox infection.
    • This vaccine is part of the Strategic National Stockpile (SNS).

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: August 23, 2022